Skip to content


  • Oral presentation
  • Open Access

The role of systems modeling in drug discovery and predictive health

Journal of Cheminformatics20102 (Suppl 1) :O2

  • Published:


  • System Biology
  • Personalized Medicine
  • Computational System
  • Biochemical System
  • Current Screening

Systems biology is the result of a confluence of recent advances in molecular biology, engineering, and the computational sciences. It can loosely be categorized into experimental and computational systems biology. Experimental high-throughput methods, assisted by robotics, image analysis, and bioinformatics, have been used in the drug industry for quite a while, and current screening tests for drug efficacy and toxicity regularly involve genomic, proteomic, and molecular modeling approaches. By contrast, the role of computational methods of biological systems analysis is still emerging. This presentation focuses on computational systems modeling and its increasingly important role at several junctures of the drug development pipeline. Examples to be discussed include mathematical models for receptor dynamics, pharmacokinetics, and metabolic and signaling pathway analysis. In the context of the latter, Biochemical Systems Theory is proposed as a highly advantageous default framework for model design, diagnostics, manipulation, and system optimization. The development of dynamic models for complex disease processes permits the straightforward inclusion of methods for custom-tailoring models, which is a key step toward personalized medicine and predictive health [15].

Authors’ Affiliations

Integrative BioSystems Institute and Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA 30332-0535, USA


  1. Voit EO: Computational Analysis of Biochemical Systems. A Practical Guide for Biochemists and Molecular Biologists. 2000, Cambridge University Press, Cambridge, UK, xii + 530Google Scholar
  2. Voit EO: Metabolic modeling: A tool of drug discovery in the post-genomic era. Drug Discovery Today. 2002, 7 (11): 621-628. 10.1016/S1359-6446(02)02280-8.View ArticleGoogle Scholar
  3. Voit EO: The dawn of a new era of metabolic systems analysis. Drug Discovery Today BioSilico. 2004, 2 (5): 182-189. 10.1016/S1741-8364(04)02419-9.View ArticleGoogle Scholar
  4. Voit EO, Brigham KL: The role of systems biology in predictive health and personalized medicine. The Open Path. J. 2008, 2: 68-70. 10.2174/1874375700802010068.View ArticleGoogle Scholar
  5. Voit EO: A systems-theoretical framework for health and disease. Math Biosc. 2009, 217: 11-18. 10.1016/j.mbs.2008.09.005.View ArticleGoogle Scholar


© Eberhard O; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.